Over a year annualised (CAGR), under a year absolute. Computed from AMFI's published
NAV history for this scheme.
Risk
Volatility
Sharpe
Sortino
Beta
Alpha
Max fall
R²
This scheme
3.6%
0.18
0.22
—
—
-8.5%
—
Risk-free rate 6.5%. Beta, alpha and R² are regressed on the
— months this scheme and its benchmark share.
Growth of ₹100 since launch
Drawdown from peak (%)
Every one-year period it has lived through
Windows
Worst
Median
Best
Periods that lost money
559
-5.0%
3.4%
13.0%
15%
Every one-year holding period in this scheme's history, not just the last one — the
spread a real investor would have met depending only on when they started.
InvestVerdict
UTI Banking & PSU Debt Fund
Regular Plan · Quarterly IDCW
Allocation
By asset
Debt
97.46%
Cash & Equivalents
2.50%
By market cap
Concentration
Number of stocks
42
Top 5 stocks
26.30%
Top 10 stocks
42.94%
Top 20 stocks
68.82%
Largest holding
7.50%
Largest sector
CRISIL-AAA 24.68%
Effective stocks
31.5
Cash
2.50%
InvestVerdict
UTI Banking & PSU Debt Fund
Regular Plan · Quarterly IDCW · holdings
Sector split
CRISIL-AAA
24.68%
CRISIL-A1+
21.52%
CARE-A1+
16.27%
ICRA-A1+
14.63%
SOV
8.96%
ICRA-AAA
7.77%
Cash & Equivalents
2.50%
CARE-AAA
2.36%
IND-AAA
1.01%
-
0.26%
A ₹10,000 monthly SIP over five years
Invested
Value
Gain
XIRR
₹600,000
₹718,784
₹118,784
7.17%
XIRR, not CAGR — a SIP's money arrives over sixty months, so each instalment has
been invested for a different length of time.
Not investment advice. InvestVerdict is not a SEBI-registered Investment
Adviser or Research Analyst. Every figure is computed from AMFI's published NAV history and the
portfolio the AMC filed with AMFI; none of it is a recommendation to buy, hold or sell. Past
returns do not predict future ones. Generated 30 Aug 2026.